10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
In the realm of antimicrobials, antifungal agents stand as a specialized arsenal against fungal pathogens. Among the diverse classes of antifungal drugs, allylamines such as terbinafine disrupt fungal cell membrane synthesis by inhibiting squalene epoxidase. This class is particularly effective against dermatophyte infections like ringworm. Flucytosine, an antimetabolite, interferes with nucleic acid synthesis in fungi. It is often used in combination with other antifungal drugs for systemic mycoses. Griseofulvin, another unique agent, disrupts fungal cell division by targeting microtubules, making it effective against dermatophyte infections of the skin, hair, and nails. As with any antimicrobial, antifungal agents require careful consideration of their side effects, drug interactions, and the specific fungal species causing the infection. The continuous development of novel antifungal agents remains imperative to stay ahead in the ongoing battle against fungal infections.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria